IRIS
SOLIMANDO, ANTONIO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.974
AS - Asia 4.486
EU - Europa 4.201
SA - Sud America 1.163
Continente sconosciuto - Info sul continente non disponibili 966
AF - Africa 269
OC - Oceania 10
Totale 20.069
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.711
SG - Singapore 1.864
IT - Italia 1.804
BR - Brasile 904
CN - Cina 831
HK - Hong Kong 510
RU - Federazione Russa 447
SE - Svezia 414
DE - Germania 410
VN - Vietnam 362
FR - Francia 346
GB - Regno Unito 227
BD - Bangladesh 218
IN - India 164
FI - Finlandia 153
CA - Canada 136
ID - Indonesia 97
AR - Argentina 72
CI - Costa d'Avorio 67
MX - Messico 62
ZA - Sudafrica 60
IQ - Iraq 57
PL - Polonia 56
TR - Turchia 56
NL - Olanda 55
CO - Colombia 53
ES - Italia 51
JP - Giappone 51
PK - Pakistan 39
BE - Belgio 38
CZ - Repubblica Ceca 38
VE - Venezuela 34
AT - Austria 31
EC - Ecuador 30
PH - Filippine 28
UA - Ucraina 28
EG - Egitto 26
LT - Lituania 26
MA - Marocco 26
SA - Arabia Saudita 26
KR - Corea 24
UZ - Uzbekistan 23
JO - Giordania 22
MY - Malesia 22
TN - Tunisia 22
CL - Cile 20
KE - Kenya 17
PY - Paraguay 17
AE - Emirati Arabi Uniti 16
IE - Irlanda 16
ET - Etiopia 14
JM - Giamaica 13
NP - Nepal 11
AU - Australia 10
DZ - Algeria 10
PE - Perù 10
BO - Bolivia 9
CR - Costa Rica 9
IR - Iran 9
UY - Uruguay 9
CH - Svizzera 8
PA - Panama 7
KW - Kuwait 6
LB - Libano 6
NI - Nicaragua 6
AO - Angola 5
HU - Ungheria 5
OM - Oman 5
PS - Palestinian Territory 5
RO - Romania 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
DK - Danimarca 4
HR - Croazia 4
IL - Israele 4
NO - Norvegia 4
PT - Portogallo 4
RS - Serbia 4
SR - Suriname 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
AL - Albania 3
BB - Barbados 3
BG - Bulgaria 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
QA - Qatar 3
SN - Senegal 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
EE - Estonia 2
GD - Grenada 2
GE - Georgia 2
GM - Gambi 2
GR - Grecia 2
HT - Haiti 2
KZ - Kazakistan 2
Totale 19.062
Salva come PNG Salva come JPEG
Città #
Ashburn 1.174
Singapore 1.100
San Jose 715
Chandler 605
Fairfield 570
Hong Kong 502
Milan 479
Council Bluffs 349
Nyköping 341
Woodbridge 306
Beijing 277
New York 264
Houston 262
Seattle 256
Cambridge 235
Los Angeles 223
Bari 207
Ann Arbor 201
Rome 185
Wilmington 176
Dallas 154
Lauterbourg 147
Munich 114
Ho Chi Minh City 112
Helsinki 109
Santa Clara 106
Dearborn 100
Roxbury 93
Lawrence 92
Boardman 90
Columbus 88
Falkenstein 84
Marseille 84
São Paulo 83
Brooklyn 71
Chicago 71
Des Moines 71
Buffalo 70
Abidjan 67
Hanoi 67
Jakarta 67
Frankfurt am Main 62
Moscow 60
Orem 49
Phoenix 49
San Diego 49
London 47
Tokyo 46
Figino 45
Montreal 44
Nanjing 44
Inglewood 40
Johannesburg 40
Denver 39
Dong Ket 39
Brussels 38
Toronto 37
Turku 36
Atlanta 34
Turin 33
Warsaw 32
Paris 31
Jacksonville 30
Stockholm 29
Chennai 27
Brno 26
The Dalles 25
Manchester 24
Naples 24
Nuremberg 24
Poplar 24
Redwood City 23
San Francisco 23
Baghdad 22
Rio de Janeiro 22
Washington 22
Boston 21
Mexico City 21
Tashkent 21
Amman 20
Guangzhou 19
Princeton 19
Campinas 18
Elk Grove Village 18
Shanghai 18
Salt Lake City 17
Curitiba 16
Dublin 16
Florence 16
Haiphong 16
Leawood 16
Mumbai 16
Tampa 16
Dhaka 15
Amsterdam 14
Augusta 14
Belo Horizonte 14
Brescia 14
Medellín 14
Pune 14
Totale 12.009
Salva come PNG Salva come JPEG
Nome #
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 303
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 252
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 228
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 225
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 221
B-Cell Therapies in Relapsing Remitting and Primary Progressive Multiple Sclerosis: A Short Clinical Review 209
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 199
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma 194
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein 193
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 193
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 192
JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma 190
Microenvironment drug resistance in multiple myeloma: Emerging new players 189
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study 189
HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma 189
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 188
Targeting B-cell non Hodgkin lymphoma: New and old tricks 177
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review 177
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 175
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 174
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 171
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 168
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 164
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 163
BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features 163
Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta‐analysis of eight studies 161
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 161
Bortezomib treatment modulates autophagy in multiple myeloma 161
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 158
A comprehensive biological and clinical perspective can drive a patient-tailored approach to multiple myeloma: Bridging the gaps between the plasma cell and the neoplastic niche 158
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 156
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 155
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment 152
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 149
Amyloid heart involvement lead a fast fatal evolution a healthy woman: a case report 149
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 148
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 148
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 145
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 144
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 143
Dyspnea, Fatigue, and Generalized Weakness in a 67-Year-Old Man: Approach to the Patient Between Guidelines and Clinical Judgment 142
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 141
Emerging Concepts in Acute Heart Failure: From the Pathophysiology to the Clinical Case Based Approach 140
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 139
A Challenging Case of Visceral Leishmaniasis 138
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib 138
Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review 138
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement 137
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 136
Actors on the scene: Immune cells in the myeloma niche 135
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 134
Angiogenesis and Antiangiogenesis in Multiple Myeloma 134
CIC-Mutation As a Potential Molecular Mechanism of Acquired Resistance to Combined BRAF/MEK Inhibition in CNS Multiple Myeloma 133
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 132
RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS 132
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 132
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 131
A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions 129
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 129
Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm 127
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion 125
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 124
Antibiotic treatment in vasculitic leg ulcers: a single center experience 123
Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research 122
Fever, cough and breathlessness in a patient with digeorge syndrome 122
Proangiogenic effect of bone marrow fibroblasts in patients with multiple myeloma 120
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 118
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 118
Two-year follow-up after drug desensitization in mucopolysaccharidosis 115
Sonography of superficial lymph nodes in malignant lymphomas. Data from our case series. 114
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 114
Genomic profiling at a single center cracks the code in inborn errors of immunity 113
LIPIDS INCREASE IN HYPERTENSIVES DURING THE FIRST YEAR STEROID TREATMENT FOR GRANULOMATOSIS WITH POLYANGIITIS (GPA) 111
Real-life experience with omalizumab in chronic spontaneous urticaria. 111
Telemedicine DSS-AI Multi Level Platform for Monoclonal Gammopathy Assistance 110
The bone marrow niche landscape: a journey through aging, extrinsic and intrinsic stressors in the haemopoietic milieu 110
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 109
Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow 109
Prognostic role of neoplastic markers in Takotsubo syndrome 109
Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting 108
Rituximab induces a reduction of lymphocyte CD3+ activated in patients with autoimmune diseases 105
CARDIOVASCULAR RISK SCORE MAY BE USEFUL IN STRATIFY DEATH RISK IN HOSPITALIZED COVID19 PATIENTS 104
Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma 104
A Markov model for estimating the cost-effectiveness of immunotherapy for newly diagnosed multiple myeloma patients 103
Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review 100
Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects 100
An atypical presentation of intestinal neuroendocrine tumor. 100
IMPACT OF REMOTE MONITORING ON PATIENTS’ QUALITY OF LIFE. A SINGLE CENTRE STUDY 99
Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation 99
Immune system and bone microenvironment: rationale for targeted cancer therapies 99
Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy 99
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 99
Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option? 98
Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside 98
Changes in Angiogenesis and Bone Turnover Markers in Patients with Gaucher Disease Developing Osteonecrosis 98
Difference in growth hormone response to growth hormone-releasing hormone (GHRH) testing following GHRH subacute treatment in normal aging and growth hormone-deficient adults: Possible perspectives for therapeutic use of GHRH or its analogs in elderly subjects? 97
Electrocardiographic Pathological Findings Caused by the SARS-CoV-2 Virus Infection: Evidence from a Retrospective Multicenter International Cohort Longitudinal Pilot Study of 548 Subjects 96
SARS-CoV-2 and Endothelial Cells: Vascular Changes, Intussusceptive Microvascular Growth and Novel Therapeutic Windows 96
STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure 96
Rituximab use in autoimmune diseases: a single center experience. 96
Totale 14.162
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.568
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022826 0 0 30 33 40 84 38 50 76 82 135 258
2022/20231.550 155 220 128 123 145 170 43 186 280 26 50 24
2023/2024866 48 121 54 76 75 258 32 21 20 24 16 121
2024/20253.613 150 57 172 130 134 313 538 355 160 220 522 862
2025/20268.795 1.066 374 498 903 1.019 483 904 312 1.033 813 448 942
2026/20271.175 399 547 229 0 0 0 0 0 0 0 0 0
Totale 20.069